Treatment with HCW9218 could block TGFβ functions through sequestration and lead to the reduction of the immunosuppressive TME, enhancing immune cell infiltration and tumor growth inhibition in mouse models [158,159]. The gene discussed is TGFB1; the disease is neoplasm.